It has recently been reported that a circulating BAFF level is positively correlated with body mass index in individuals with obesity [3], and patients with non-alcoholic fatty liver disease have increased levels of serum BAFF [4]. This evidence concerns the gene TNFSF13B and metabolic dysfunction-associated steatotic liver disease.